2.10
-0.20 (-8.70%)
| Penutupan Terdahulu | 2.30 |
| Buka | 2.30 |
| Jumlah Dagangan | 92,374 |
| Purata Dagangan (3B) | 2,806,763 |
| Modal Pasaran | 19,819,968 |
| Harga / Buku (P/B) | 2.01 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -2,518.17% |
| EPS Cair (TTM) | -0.240 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 56.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 25.43% |
| Nisbah Semasa (MRQ) | 0.080 |
| Aliran Tunai Operasi (OCF TTM) | -1.07 M |
| Pulangan Atas Aset (ROA TTM) | -8.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -21.00% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | Gelteq Limited | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.50 |
|
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| % Dimiliki oleh Orang Dalam | 60.36% |
| % Dimiliki oleh Institusi | 1.11% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Wedbush Securities Inc | 31 Mar 2025 | 52,250 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Jun 2025 | Pengumuman | Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |